[REGN] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
05-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -21.14%
YoY- 35.46%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 3,162,100 2,965,100 2,528,700 1,828,200 1,711,800 1,511,485 1,318,991 15.68%
PBT 858,000 1,061,100 1,253,000 668,600 546,100 585,398 432,289 12.09%
Tax 40,200 87,600 137,800 44,000 85,000 107,418 183,358 -22.33%
NP 817,800 973,500 1,115,200 624,600 461,100 477,980 248,931 21.91%
Tax Rate -4.69% -8.26% -11.00% -6.58% -15.56% -18.35% -42.42% -
Total Cost 2,344,300 1,991,600 1,413,500 1,203,600 1,250,700 1,033,505 1,070,060 13.95%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin 25.86 32.83 44.10 34.16 26.94 31.62 18.87 5.38%
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS 7.64 8.61 10.58 5.69 4.23 4.44 2.36 21.61%
EPS Diluted 7.17 8.61 10.09 5.43 3.99 4.16 2.16 22.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.